Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Thunnissen, E; Weynand, B; Udovicic-Gagula, D; Brcic, L; Szolkowska, M; Hofman, P; Smojver-Ježek, S; Anttila, S; Calabrese, F; Kern, I; Skov, B; Perner, S; Dale, VG; Eri, Z; Haragan, A; Leonte, D; Carvallo, L; Prince, SS; Nicholson, S; Sansano, I; Ryska, A.
Lung cancer biomarker testing: perspective from Europe.
Transl Lung Cancer Res. 2020; 9(3): 887-897. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Brcic Luka
Altmetrics:

Dimensions Citations:

Plum Analytics:
Number of Figures: 3
| | |
Abstract:
A questionnaire on biomarker testing previously used in central European countries was extended and distributed in Western and Central European countries to the pathologists participating at the Pulmonary Pathology Society meeting 26-28 June 2019 in Dubrovnik, Croatia. Each country was represented by one responder. For recent biomarkers the availability and reimbursement of diagnoses of molecular alterations in non-small cell lung carcinoma varies widely between different, also western European, countries. Reimbursement of such assessments varies widely between unavailability and payments by the health care system or even pharmaceutical companies. The support for testing from alternative sources, such as the pharmaceutical industry, is no doubt partly compensating for the lack of public health system support, but it is not a viable or long-term solution. Ideally, a structured access to testing and reimbursement should be the aim in order to provide patients with appropriate therapeutic options. As biomarker enabled therapies deliver a 50% better probability of outcome success, improved and unbiased reimbursement remains a major challenge for the future. 2020 Translational Lung Cancer Research. All rights reserved.

Find related publications in this database (Keywords)
Lung cancer
predictive testing
therapy
health care
Europe
© Med Uni Graz Impressum